AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32474816 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine chemotherapy
Number of subjects: 0
Study 32474816 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 0
Study 35858154 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Paclitaxel plus Encequidar (oPac + E) 205 mg/m2 paclitaxel plus 15 mg E, 3 consecutive days per week
Number of subjects: 402
Study 35858154 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Paclitaxel (IVpac) 175 mg/m2 once every 3 weeks
Number of subjects: 402
Study 35858154 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Paclitaxel plus Encequidar (oPac + E)
Number of subjects: 402
Study 35858154 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Paclitaxel (IVpac)
Number of subjects: 402
Study 32959110 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg of ASA administered in the evening (n = 56)
Number of subjects: 114
Study 32959110 — intervention group
Group type: COMPARATOR
Intervention: 75 mg of ASA administered in the morning (n = 58)
Number of subjects: 114
Study 32959110 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 61) - patients with arterial hypertension but without coronary heart disease, not receiving ASA
Number of subjects: 114
Study 32957353 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS in M1 area on the contralateral side and 3 Hz rTMS at Neiguan and Sanyinjiao points
Number of subjects: 42
Study 32957353 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture (body acupuncture)
Number of subjects: 42
Study 36038163 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobe-specific lymph node dissection (L-SLND)
Number of subjects: 1344
Study 36038163 — intervention group
Group type: COMPARATOR
Intervention: Systematic lymph node dissection (SLND)
Number of subjects: 1344
Study 34964825 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection (US)
Number of subjects: 117
Study 34964825 — intervention group
Group type: COMPARATOR
Intervention: Freehand injection (FH)
Number of subjects: 117
Study 35221930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortico–peripheral Hebbian-type stimulation (HTS)
Number of subjects: 90
Study 35221930 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 90
Study 32046718 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic artemether-lumefantrine (Artefan®)
Number of subjects: 0
Study 32046718 — intervention group
Group type: COMPARATOR
Intervention: Innovator artemether-lumefantrine (Coartem®)
Number of subjects: 0
Study 34379539 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 126
Study 34379539 — intervention group
Group type: COMPARATOR
Intervention: Not given chewing gum (Control)
Number of subjects: 126
Study 32649717 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (INF)
Number of subjects: 82
Study 32649717 — intervention group
Group type: COMPARATOR
Intervention: Intravenous hydromorphone (IVH)
Number of subjects: 82
Study 36115273 — intervention group
Group type: EXPERIMENTAL
Intervention: White individual
Number of subjects: 1833
Study 36115273 — intervention group
Group type: COMPARATOR
Intervention: White female
Number of subjects: 1833
Study 36115273 — intervention group
Group type: COMPARATOR
Intervention: Black male
Number of subjects: 1833
Study 36115273 — intervention group
Group type: EXPERIMENTAL
Intervention: Male individual transitioning to heroin
Number of subjects: 1833
Study 32333876 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 3 mg
Number of subjects: 458
Study 32333876 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 7 mg
Number of subjects: 458
Study 32333876 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral semaglutide 14 mg
Number of subjects: 458
Study 32333876 — intervention group
Group type: COMPARATOR
Intervention: Dulaglutide 0.75 mg
Number of subjects: 458
Study 35564858 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Resistance Exercise (HCRE)
Number of subjects: 30
Study 35564858 — intervention group
Group type: COMPARATOR
Intervention: Control (activities of daily living)
Number of subjects: 30
Study 34227949 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted client communication intervention using text messages, tailored to pregnant and postpartum women, developed through co-design and theory-based approaches.
Number of subjects: 26
Study 32700798 — intervention group
Group type: EXPERIMENTAL
Intervention: S-Praziquantel (S-PZQ) with ketoconazole (KTZ) as a CYP3A inhibitor
Number of subjects: 0
Study 32700798 — intervention group
Group type: EXPERIMENTAL
Intervention: R-Praziquantel (R-PZQ) with ketoconazole (KTZ) as a CYP3A inhibitor
Number of subjects: 0
Study 35412448 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling plus upper cervical spinal manipulation
Number of subjects: 120
Study 35412448 — intervention group
Group type: COMPARATOR
Intervention: Interocclusal splint therapy, diclofenac, and TMJ mobilization
Number of subjects: 120
Study 33494639 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 0
Study 33494639 — intervention group
Group type: COMPARATOR
Intervention: Intervention designed to obliterate the AVM
Number of subjects: 0
Study 32997684 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Message Service (SMS) intervention providing danger sign messages
Number of subjects: 0
Study 32997684 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Message Service (SMS) intervention providing family planning messages
Number of subjects: 0
Study 32997684 — intervention group
Group type: COMPARATOR
Intervention: Standard of care only (control group)
Number of subjects: 0
Study 35840960 — intervention group
Group type: EXPERIMENTAL
Intervention: Training programme for Pharmacist Independent Prescribers (PIPs) including two training days, professional development planning, mentor support, and a viva with an independent GP
Number of subjects: 25
Study 35840960 — intervention group
Group type: EXPERIMENTAL
Intervention: Training programme for Pharmacist Independent Prescribers (PIPs)
Number of subjects: 25
Study 34967368 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 180
Study 34967368 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture (LA)
Number of subjects: 180
Study 34967368 — intervention group
Group type: COMPARATOR
Intervention: Sham laser acupuncture (C)
Number of subjects: 180
Study 34557930 — intervention group
Group type: EXPERIMENTAL
Intervention: [68 Ga]Ga‐P16‐093
Number of subjects: 20
Study 33682970 — intervention group
Group type: EXPERIMENTAL
Intervention: Real high‐efficiency particulate air filter (HEPA)
Number of subjects: 54
Study 33682970 — intervention group
Group type: COMPARATOR
Intervention: Sham high‐efficiency particulate air filter (HEPA)
Number of subjects: 54
Study 32568867 — intervention group
Group type: COMPARATOR
Intervention: Entecavir monotherapy (n = 70)
Number of subjects: 144
Study 32568867 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir add-on peg-interferon therapy (n = 74)
Number of subjects: 144
Study 32568867 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (monotherapy and combination therapy)
Number of subjects: 144
Study 35653637 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl
Number of subjects: 2146
Study 33748055 — intervention group
Group type: EXPERIMENTAL
Intervention: ESRα promoter methylation levels
Number of subjects: 1143
Study 33748055 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglyceride (TG)
Number of subjects: 1143
Study 33748055 — intervention group
Group type: EXPERIMENTAL
Intervention: High density lipoprotein cholesterol (HDL‐C)
Number of subjects: 1143
Study 33748055 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower methylation levels (≤4.07%)
Number of subjects: 1143
Study 32017167 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month supplementation with carnitines and other micronutrients
Number of subjects: 104
Study 35804307 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (cisplatin and 5-fluorouracil plus radiotherapy followed by surgical resection)
Number of subjects: 96
Study 35804307 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant therapy (cisplatin, 5-fluorouracil, and epirubicin chemotherapy with concurrent extended volume radiotherapy following surgical resection)
Number of subjects: 96
Study 35804307 — intervention group
Group type: EXPERIMENTAL
Intervention: Any observed increase in CTCs
Number of subjects: 96
Study 34916645 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical peri-implantitis treatment combined with systemic antimicrobials
Number of subjects: 60
Study 34916645 — intervention group
Group type: COMPARATOR
Intervention: Full mouth non-surgical peri-implantitis treatment
Number of subjects: 60
Study 35560305 — intervention group
Group type: EXPERIMENTAL
Intervention: High Sodium (HS) diet (6,900 mg/day) with Placebo (PL)
Number of subjects: 10
Study 35560305 — intervention group
Group type: EXPERIMENTAL
Intervention: High Sodium (HS) diet (6,900 mg/day) with Antioxidants (AO)
Number of subjects: 10
Study 35560305 — intervention group
Group type: COMPARATOR
Intervention: Low Sodium (LS) diet (2,300 mg/day) with Placebo (PL)
Number of subjects: 10
Study 35560305 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Sodium (LS) diet (2,300 mg/day) with Antioxidants (AO)
Number of subjects: 10
Study 34438029 — intervention group
Group type: EXPERIMENTAL
Intervention: SZL (3.2 g/d)
Number of subjects: 156
Study 34438029 — intervention group
Group type: COMPARATOR
Intervention: FLX (20 mg/d)
Number of subjects: 156
Study 35119243 — intervention group
Group type: EXPERIMENTAL
Intervention: Amniotic membrane (AM)
Number of subjects: 34
Study 35119243 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 32857944 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal thrust manipulation and electrical dry needling (TMEDN group)
Number of subjects: 145
Study 32857944 — intervention group
Group type: COMPARATOR
Intervention: Nonthrust peripheral joint/soft tissue mobilization, exercise, and interferential current (NTMEX group)
Number of subjects: 145
Study 34737549 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% Hyaluronic Acid (HA)
Number of subjects: 50
Study 34737549 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 36293787 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual lifestyle coaching
Number of subjects: 319
Study 36293787 — intervention group
Group type: EXPERIMENTAL
Intervention: Group lifestyle coaching
Number of subjects: 319
Study 36293787 — intervention group
Group type: COMPARATOR
Intervention: Control group for individual coaching
Number of subjects: 319
Study 36293787 — intervention group
Group type: COMPARATOR
Intervention: Control group for group coaching
Number of subjects: 319
Study 34918639 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth potassium citrate capsules (220 mg)
Number of subjects: 240
Study 34918639 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth pectin capsules (200 mg)
Number of subjects: 240
Study 34918639 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth pectin granules (150 mg)
Number of subjects: 240
Study 34918639 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth pectin granules (300 mg)
Number of subjects: 240
Study 34918639 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 240
Study 35589494 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) during walking exercise (60% arterial occlusion pressure)
Number of subjects: 16
Study 35589494 — intervention group
Group type: COMPARATOR
Intervention: Walking exercise without Blood Flow Restriction (Control)
Number of subjects: 16
Study 32563609 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dosage sIPV
Number of subjects: 240
Study 32563609 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dosage sIPV
Number of subjects: 240
Study 32563609 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dosage sIPV
Number of subjects: 240
Study 32563609 — intervention group
Group type: COMPARATOR
Intervention: Salk IPV (reference)
Number of subjects: 240
Study 34783875 — intervention group
Group type: EXPERIMENTAL
Intervention: SoC + noncontrast CT
Number of subjects: 862
Study 34783875 — intervention group
Group type: COMPARATOR
Intervention: SoC
Number of subjects: 862
Study 33770374 — intervention group
Group type: EXPERIMENTAL
Intervention: 1mm PSF reconstruction
Number of subjects: 46
Study 33770374 — intervention group
Group type: COMPARATOR
Intervention: EARL-compliant reconstruction
Number of subjects: 46
Study 33770374 — intervention group
Group type: COMPARATOR
Intervention: Standard reconstruction
Number of subjects: 46
Study 32105353 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity program
Number of subjects: 1635
Study 32105353 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 1635
Study 36304071 — intervention group
Group type: EXPERIMENTAL
Intervention: iNPWT for 14 postoperative days
Number of subjects: 20
Study 36304071 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound dressing
Number of subjects: 20
Study 36437131 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive robot during postoperative mobilization
Number of subjects: 84
Study 36437131 — intervention group
Group type: COMPARATOR
Intervention: Standard care during mobilization
Number of subjects: 84
Study 33414503 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP (Continuous Positive Airway Pressure) treatment
Number of subjects: 0
Study 33414503 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment
Number of subjects: 0
Study 33414503 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 0
Study 33027267 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one health education and educational brochures about cervical cancer and cervical cancer screening.
Number of subjects: 2140
Study 33027267 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 2140
Study 33027267 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one health education and educational brochures.
Number of subjects: 2140
Study 33027267 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational status of the first degree.
Number of subjects: 2140
Study 33027267 — intervention group
Group type: EXPERIMENTAL
Intervention: History of sexually transmitted infections (STIs).
Number of subjects: 2140
Study 35367978 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (carbon‐fiber support board and hollowed‐out cervicothoracic thermoplastic mask)
Number of subjects: 40
Study 35367978 — intervention group
Group type: COMPARATOR
Intervention: Group B (only carbon‐fiber support board)
Number of subjects: 40
Study 35367978 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 40
Study 35367978 — intervention group
Group type: COMPARATOR
Intervention: Group B
Number of subjects: 40
Study 32370818 — intervention group
Group type: EXPERIMENTAL
Intervention: escitalopram 10 mg/tab daily
Number of subjects: 111
Study 32370818 — intervention group
Group type: EXPERIMENTAL
Intervention: moclobemide 150 mg/tab daily
Number of subjects: 111
Study 32370818 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 111
Study 32370818 — intervention group
Group type: EXPERIMENTAL
Intervention: escitalopram and moclobemide
Number of subjects: 111
Study 34473848 — intervention group
Group type: EXPERIMENTAL
Intervention: Training toward initial theoretical optimal FV-profile
Number of subjects: 40
Study 34473848 — intervention group
Group type: EXPERIMENTAL
Intervention: Training away from initial theoretical optimal FV-profile
Number of subjects: 40
Study 34473848 — intervention group
Group type: EXPERIMENTAL
Intervention: Training irrespective of initial theoretical optimal FV-profile
Number of subjects: 40
Study 32316129 — intervention group
Group type: EXPERIMENTAL
Intervention: Passiflora setacea juice (250 mL)
Number of subjects: 12
Study 32316129 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PB)
Number of subjects: 12
Study 36241898 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (HIIT), 12 weeks, 3 times weekly on a rowing ergometer, average power output of 138 W
Number of subjects: 142
Study 36241898 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 142
Study 36241898 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (HIIT)
Number of subjects: 142
Study 33527578 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual support using smartglass technology during TAVR proctoring
Number of subjects: 2
Study 32807632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) with aerobic exercise plus usual care (UC)
Number of subjects: 187
Study 32807632 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 187
Study 35233923 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic surgery (Roux-en-Y gastric bypass, adjustable gastric band, or sleeve gastrectomy)
Number of subjects: 302
Study 35233923 — intervention group
Group type: COMPARATOR
Intervention: Medical/lifestyle intervention
Number of subjects: 302
Study 35233923 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic surgery
Number of subjects: 302
Study 32095843 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine
Number of subjects: 117
Study 32095843 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine + Tramadol 1 mg/kg (P + T1)
Number of subjects: 117
Study 32095843 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine + Tramadol 2 mg/kg (P + T2)
Number of subjects: 117
Study 32095843 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (Control group)
Number of subjects: 117
Study 35285803 — intervention group
Group type: EXPERIMENTAL
Intervention: BP-PtCr-EES with 4 months DAPT
Number of subjects: 818
Study 35285803 — intervention group
Group type: COMPARATOR
Intervention: DP-CoCr-EES with 12 months DAPT
Number of subjects: 818
Study 32015256 — intervention group
Group type: EXPERIMENTAL
Intervention: iHEART intervention (smartphone-based electrocardiogram monitoring and motivational text messages)
Number of subjects: 238
Study 32015256 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 238
Study 35473345 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger-indirect moxibustion plus acupuncture
Number of subjects: 290
Study 35473345 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 290
Study 34554649 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based aerobic exercise at 40-60% peak heart rate thrice weekly and resistance training at 70% of one-repetition maximum twice weekly for 6 months
Number of subjects: 46
Study 34554649 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based aerobic exercise and resistance training
Number of subjects: 46
Study 34554649 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 46
Study 35603664 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger millet muffin
Number of subjects: 29
Study 35603664 — intervention group
Group type: COMPARATOR
Intervention: Wheat muffin
Number of subjects: 29
Study 33683782 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% deoxyarbutin
Number of subjects: 59
Study 33683782 — intervention group
Group type: COMPARATOR
Intervention: 4% hydroquinone
Number of subjects: 59
Study 36138535 — intervention group
Group type: EXPERIMENTAL
Intervention: Early administration of TXA (2 g bolus within 45 minutes of injury)
Number of subjects: 649
Study 36138535 — intervention group
Group type: COMPARATOR
Intervention: Late administration of TXA (1 g bolus plus 1 g 8 h infusion after 45 minutes of injury)
Number of subjects: 649
Study 33277160 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized surgical guide with fixation plates (splintless group)
Number of subjects: 16
Study 33277160 — intervention group
Group type: COMPARATOR
Intervention: Intermediate CAD/CAM splint (splint group)
Number of subjects: 16
Study 33277160 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 16
Study 33566212 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 prevention recommendations
Number of subjects: 96
Study 33566212 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV care visits
Number of subjects: 96
Study 33566212 — intervention group
Group type: EXPERIMENTAL
Intervention: Trust in information sources
Number of subjects: 96
Study 33566212 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth access
Number of subjects: 96
Study 33566212 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge from HIV pandemic
Number of subjects: 96
Study 32622781 — intervention group
Group type: EXPERIMENTAL
Intervention: cGAN
Number of subjects: 173
Study 32622781 — intervention group
Group type: EXPERIMENTAL
Intervention: cycleGAN
Number of subjects: 173
Study 35253077 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity antenatal primary care intervention focusing on diet and physical activity
Number of subjects: 0
Study 35253077 — intervention group
Group type: COMPARATOR
Intervention: Maternal BMI at enrollment
Number of subjects: 0
Study 32457012 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg intravenous)
Number of subjects: 110
Study 32457012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 36231604 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurorehabilitation treatment plus ultrasound-guided dry needling
Number of subjects: 20
Study 36231604 — intervention group
Group type: COMPARATOR
Intervention: Neurorehabilitation treatment
Number of subjects: 20
Study 33961812 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-stand exercises and protein-rich nutritional supplements (12-week intervention)
Number of subjects: 101
Study 33961812 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-stand exercises and protein-rich nutritional supplements
Number of subjects: 101
Study 33961812 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-stand exercises
Number of subjects: 101
Study 33961812 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention (nutrition and exercise)
Number of subjects: 101
Study 33961812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 101
Study 33961812 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101